5/31/2025CSPC Eyes $5B in Licensing Deals for EGFR-ADC and Innovative Therapies

5/31/2025Astellas Enters Exclusive License Agreement with Evopoint Biosciences ...

5/31/2025Ivonescimab Hits Key Milestone in Phase III HARMONi Trial for EGFR-Mut...

5/31/2025Former CFDA Commissioner Bi Jingquan Under Investigation for Serious ...

5/29/2025First Patient Dosed in YK012 Trial -The World's First TCE Therapy for ...

5/29/2025CDE Solicits Comments on Draft Technical Considerations for NMR Studi...

5/29/2025CDE Issues Guideline on Production Site Change Research for Licensed B...

5/29/2025CDE Launches “Starlight Plan” to Encourage Pediatric Antitumor Drug ...

5/29/2025CDE Issues Guideline on Safety Assessment and Reporting in Pediatric D...

5/29/2025AusperBio Secures $50M in Series B+ Financing

5/29/2025Rona Unveils Promising Preclinical Data for Annual RNAi Therapy

5/29/2025Livzon Acquires Majority Stake in Vietnam's Imexpharm for $221 Million

5/29/2025China Grants Conditional Approval to Hengrui's Famitinib

5/29/2025China Approves Zelgen's Gecacitinib

5/29/2025China Grants Conditional Approval to Two HER2-Targeted Therapies for A...

5/29/2025Kanion's Generic Sumatriptan/Naproxen Gains Approval in China

5/29/2025China Approves Two New CDK4/6 Inhibitors for Advanced Breast Cancer

5/29/2025Merck Pursues Global Approvals for Pimicotinib Following Positive Phas...

5/29/2025Kelun-Biotech Initiates Phase 1 Trial for SKB571, a Bispecific ADC Tar...

5/29/2025Novartis Secures NMPA Approval for Beovu for DME in China

5/29/2025Minghui Advances IGF-1R Antibody MHB018A to Phase 3 for TED

5/28/2025Vigene and Merz Expand Strategic Partnership Across Greater China

5/28/2025Novartis Broadens Alliance with Shanghai Pharma to Include Eye Drugs i...

5/27/2025Pharma Distribution Market Steady with 5.6% Growth in the 14th FYP

5/27/2025Salubris Invests CNY 550M in Next-Gen Hypertension siRNA Therapy with ...

5/27/2025Hengrui's c-MET-Targeted ADC SHR-1826 Shows Promising Results in Phase...

5/27/2025Eisai's Dayvigo Receives Approval in China for Insomnia

5/27/2025PegBio Debuts on HKEx, Raising HK$300M to Advance GLP-1 Therapies

5/27/2025DualityBio's HER3-Targeted ADC DB-1310 Shows Promising Early Results i...

5/27/2025Salubris Pharma's S086 Receives Chinese Approval for Hypertension Trea...

Page:51/61 Total number of articles:1813: [First][<<] [49] [50] [51] [52] [53] [>>] [End]